Quality of Life After Radiofrequency Ablation of Pancreatic Cancer
Not Applicable
Completed
- Conditions
- Pancreatic Cancer
- Registration Number
- NCT02637596
- Lead Sponsor
- Brno University Hospital
- Brief Summary
A prospective clinical study evaluating quality of life (QoL) in pancreatic cancer patients treated with intraoperative radiofrequency ablation (RFA).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
- histologically proved locally advanced or metastatic pancreatic cancer. Patients with histologically proved resectable pancreatic cancer with low Karnofsky index.
informed consent
Exclusion Criteria
- cystic tumor
age under 18
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Quality of life after RFA of pancreatic cancer 3 years Quality of life will be evaluated using EORTC C 30 and pan 26 questionaire preoperatively and three months after RFA
- Secondary Outcome Measures
Name Time Method 3- months perioperative morbidity and mortality 3 years Three months morbidity and mortality will be evaluated using Dindo-Clavien classification
Trial Locations
- Locations (1)
Department of surgery Masaryk University Hostpital Brno
🇨🇿Brno, Bohunice, Czech Republic
Department of surgery Masaryk University Hostpital Brno🇨🇿Brno, Bohunice, Czech Republic